HT VISTA & VISTA IQ

Assess the risk of cancer in just a few minutes!

Play video

Skin Cancer Detection in Dogs for dogs.

Using Heat Diffusion Imaging (HDI) and an artificial intelligence algorithm, veterinary professionals can distinguish between normal and malignant tissue in dermal and subcutaneous masses in dogs within a few minutes.

Diagnosis of common tumor types:

In all cases where VISTA IQ and HT Vista detect a low or high probability of malignancy, benign tumors such as lipomas or malignant tumors such as mast cell tumors can be diagnosed. This avoids unnecessary invasive procedures for lipomas and enables mast cell tumors to be detected at an early stage.

More cancer screening with VISTA IQ

Cancer is the most common cause of death in dogs.

1/3 of tumors are located on or under the skin. Unfortunately, many lumps or bumps are still not examined in detail today.

Early screening is the most important and effective step in cancer treatment.

Many dermal and subcutaneous masses remain undiagnosed

Did you know that...

• 15% of dermal and subcutaneous masses are malignant. That's 3 our of 20.
• 38% of all lumps or bumps are examined by fine-needle aspiration (FNA).
• 19% of the samples are examined by a pathologist.
• 30% of dogs have more than one mass.
• Read the full report on the HT Vet website .

Cancer risk assessment

With VISTA IQ, the successor to HT Vista, HT-VET has developed an innovative system that uses patented and validated imaging technology and Artificial Intelligence to simplify the examination of lumps and bumps.

The underlying principle of VISTA iQ Heat Diffusion Imaging (HDI) technology is that benign and malignant tissues display different Heat Transfer Rates due to differences in composition, metabolism, tissue morphology, and vascular networks, which affect their thermophysical properties. This innovative screening modality relies on the unique thermal signals recorded by the device, as the tissue is heated and left to cool down.

Unique new technology

HTVet is the first AI-driven non-invasive screening tool that enables veterinarians and their specialist staff to evaluate the cancer risk in subcutaneous and dermal masses using heat diffusion imaging (HDI) and artificial intelligence, and to obtain diagnoses.

This innovative patented imaging modality relies on unique thermal signals that differ between normal and malignant tissues, as they are recorded by the device.

Using artificial intelligence, the algorithm compares the patient's signal with previously learned signals and calculates the probability of malignancy.

Cancer detection with screening and diagnostic function

Advances in artificial intelligence and the steadily growing number of validated masses, now numbering almost 1,200, have enabled the programming of two new functions in screening:

Assessment of cancer risk in three stages: The visual representation of cancer risk in three stages supports rapid assessment of lumps and bumps immediately after examination.

It assists in decision-making by identifying low-risk cases that can be safely monitored and recommending next steps for medium- and high-risk cases.

The cancer risk is presented based on the probability of malignancy.

Screening results are based on a Sensitivity (Sen) of 90% and a Negative Predictive Value (NPV) of 98%.

Diagnosis with 90% specificity for

• Lipoma, Benign Epithelials, Sebaceous Adenomas
• Mast Cell Tumors, Soft Tissue Sarcomas (coming soon)

Low risk:

1 in 50 chance of malignancy.
Monitoring with routine follow up is recommended.

Moderate Risk

1 in 4 chance of malignancy.
Further investigation is recommended due to elevated risk

High Risk

2 in 3 chance of malignancy.
Further investigation is recommended due to elevated risk.

AI-supported tumor subclassification:

Following the assessment of cancer risk, benign tumors such as lipomasand malignant tumors such as mast cell tumors (MCTs) are diagnosed.

In all cases where HT Vista determines a very low or very high probability of malignancy, a diagnosis of the tumor type is made using a specifity of at least 90% . This avoids unnecessary invasive procedures for benign lipomas and enables early detection of MCTs.

Read the full article -> HT Vista 4.0: Introducing HT Vista's New Diagnostic Capability

On the web page of HTVet you will find the latest international press releases and news.

Advantages of cancer screening with VISTA IQ and HT Vista

Direct at your point of care

Examination and results on site.

Non-invasive

A stress, and risk free experience for patient and owner.

Affordable

Cost-effective screening with rapid return on investment.

Result in 5 minutes

With Artificial Intelligence generated result.

98% Negative Predictive Value (NPV) in avg.

90% sensitivity

Easy to use

Suitable for all your technical staff.

^{Result in a few minutes}

Preparation scan

Trim the fur in the affected area so that sufficient tissue can be examined.

Scanning

Hold the scanner against the affected area for a non-invasive scan lasting 40 seconds.

Result

After a few minutes, you will receive your cancer risk assessment and a possible diagnosis.

Testimonials

"We've had the great opportunity to use the HT Vista technology over the last few months in our hospital. It fits right into the way we handle lumps and bumps in our canine patients. The procedure is quick, simple, can be performed by our nurse team, and gives us the vets good guidelines as to how to proceed with these cases. It's a great tool to give quick peace of mind to pet owners and motivate them to make the best choices for the onward diagnosis and treatment of their pets."

Dr. med.vet. Elisabet Ellström, DVMSmådjurskliniken Din Veterinär, Sweden

"Our experience with HT Vista has been remarkably positive. As a Diplomate of Veterinary Oncology, I can attest to the product's significant value. It enhances diagnostic precision and supports comprehensive patient care. HT Vista stands out as a crucial tool for our practice, providing reliable results and aiding in the early detection of oncological skin cancer."

Dr. Ondřej Škor Dipl. ECVIM-CA (Oncology)Regia Vet - Prague, Czech Republic

“I am a Diplomate of Veterinary Oncology, and my experience with HT Vista has been excellent! It is highly precise as a screening tool for dermal and subcutaneous masses. With the help of HT Vista, we can differentiate between benign masses and those that may require further testing—without any invasive procedures. This means that invasive procedures are only necessary for dogs with potentially concerning masses. HT Vista lowers the barrier for clients to have dermal and subcutaneous masses checked, which leads to earlier detection of skin tumors.”

Dr. med. vet. Dipl ACVIM (SAIM & Onc) Clinical DirectorMarigin – Zentrum für Tiermedizin, Feusisberg, Switzerland

“ HT Vista has proven to be a reliable, non-invasive supplement for dealing with cutaneous or subcutaneous masses and is a valued aid for pet owners when deciding how to deal with potential tumors.”

Dr. med.vet. Filippo BentivoglioKleintierklinik und Pferdepraxis in St. Gallen, Switzerland

"I work as an all-rounder in small animal medicine and, as a qualified behavioral medicine specialist, I attach great importance to a low-stress examination. That's why I'm happy about the tumor scanner from HT Vista, as it enables a non-invasive and therefore pain-free examination of skin tumors. I am also happy to support new technologies that will lead our medicine into the future."

Dr. med. vet. Simone KundertLutraVet Kleintierpraxis in Männedorf, Switzerland

"The HT Vista has transformed the way how we investigate lumps in dogs at Max and Min Veterinary Practice.
We now use the device to screen every cutaneous or subcutaneous lump that we see in our canine patients prior to obtaining an aspirate. We have seen the greatest impact in patients with multiple, long-standing skin masses where owners can be reluctant to aspirate or biopsy multiple lesions and are more concerned about the risk of GA or sedation. The non-invasive nature of the HT Vista is much more appealing to pet owners and gives a quick result within minutes! In addition, the algorithm and AI is constantly evolving and learning from the samples that are taken and so I am confident the scanner will offer more features in the future!"

Dr. Huw Morgan-Jones MRCVSMax and Min Veterinary Practice, UK

Includes

VISTA IQ Scanner

Portable, wireless HDI scanner

Docking Station

Charging station with bracket

Power cord

with 220V for Switzerland or the EU

Flexible frames

Extensions in various sizes

Development and manufacturing

HT Vista and VISTA IQ were developed together with veterinary oncologists and specialists in innovative imaging techniques and artificial intelligence. The algorithms for analyzing cutaneous and subcutaneous masses are continuously trained and developed. The system learns with each new scan.

The system is developed and manufactured in the USA according to medical technology guidelines and is approved for use in veterinary medicine. 

P12 Medical imports the devices to Switzerland, inspects, trains, and supports you after purchase. The system complies with all regulatory requirements in Switzerland and the EU.

HT Vista

The first model, HT Vista from HT-Vet, is still available as an affordable entry-level model. It can be upgraded to VISTA IQ at any time.